Department of Obstetrics and Gynaecology, Vito Fazzi Hospital, Lecce, Italy.
Int J Gynecol Cancer. 2013 Jun;23(5):956-63. doi: 10.1097/IGC.0b013e31828eeea4.
Lymphoceles are among the most common postoperative complications of pelvic lymphadenectomy (PL), with a reported incidence of 1% to 50%. Symptoms are pelvic pain, leg edema, gastrointestinal obstruction, obstructive uropathy, and deep vein thrombosis, and severe complications such as sepsis and lymphatic fistula formation. After laparoscopic PL, we tested the prevention of lymphoceles using collagen patch coated with the human coagulation factors (TachoSil, Nycomed International Management GmbH, Zurich, Switzerland) on 55 patients with endometrial cancer stages IB to II who had undergone laparoscopy.
The authors divided the patients into 2 laparoscopy groups: PL plus TachoSil (group 1: 26 patients) and PL without TachoSil in a control group (group 2: 29 patients), as historical cohort of patients who underwent PL between 2010 and 2012. We collected surgical parameters, and the patients underwent ultrasound examination on postoperative days 7, 14, and 28. The main outcome measures were the development of symptomatic or asymptomatic lymphoceles, the need for further surgical intervention, as adverse effect of surgery, and the drainage volume and duration.
The same number of lymph nodes in both groups was removed; group 1 showed a lower drainage volume. Lymphoceles developed in 5 patients in group 1 and in 15 patients in group 2; of these, only 2 patients were symptomatic in group 1 and 5 patients were symptomatic in group 2, without statistical difference and no percutaneous drainage request.
In this preliminary investigation, the intraoperative laparoscopy application of TachoSil seems to reduce the rate of postoperative lymphoceles after PL, providing a useful additional treatment option for reducing drainage volume and preventing lymphocele development after PL.
盆腔淋巴结清扫术(PL)后发生淋巴囊肿是最常见的术后并发症之一,其发生率为 1%至 50%。症状包括盆腔疼痛、下肢水肿、胃肠道梗阻、尿路梗阻和深静脉血栓形成,以及严重并发症如败血症和淋巴瘘形成。在腹腔镜 PL 后,我们对 55 例子宫内膜癌 IB 至 II 期患者使用涂有人凝血因子的胶原蛋白贴片(TachoSil,Nycomed International Management GmbH,苏黎世,瑞士)预防淋巴囊肿,这些患者均接受了腹腔镜手术。
作者将患者分为 2 个腹腔镜组:PL 加 TachoSil(组 1:26 例)和 PL 不加 TachoSil 的对照组(组 2:29 例),作为 2010 年至 2012 年期间接受 PL 的患者的历史队列。我们收集了手术参数,术后第 7、14 和 28 天对患者进行超声检查。主要观察指标为有症状或无症状淋巴囊肿的发展、是否需要进一步手术干预、手术的不良反应以及引流量和引流时间。
两组淋巴结清扫数量相同;组 1的引流量较低。组 1有 5 例患者发生淋巴囊肿,组 2有 15 例患者发生淋巴囊肿;其中,组 1仅 2 例患者出现症状,组 2有 5 例患者出现症状,但无统计学差异,也无需进行经皮引流。
在这项初步研究中,TachoSil 在腹腔镜手术中的应用似乎降低了 PL 后术后淋巴囊肿的发生率,为减少 PL 后引流量和预防淋巴囊肿的发生提供了一种有用的额外治疗选择。